Teladoc Health, Inc. (TDOC) stock
TDOCNYSEServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/3041% below fair value
$8.49−0.21 (-2.41%)
Close on Nov 17, 2026Market cap $1.55BP/E –Yield –
Teladoc Health r&d expenses
Research and development expenses are spending on new products and technology.
Teladoc Health's R&D Expenses for the twelve months ending Sep 30, 2026 was $267.88M, down 5.4% year over year. For fiscal 2025 it was $277.92M, down 9.6% from the year before. Over ten years it grew 34.6% a year on average. The highest annual figure on record is $348.52M in fiscal 2023.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $277.92M | -9.6% |
| FY2024 | Dec 31, 2024 | $307.27M | -11.8% |
| FY2023 | Dec 31, 2023 | $348.52M | +4.5% |
| FY2022 | Dec 31, 2022 | $333.63M | +7.0% |
| FY2021 | Dec 31, 2021 | $311.88M | +89.1% |
| FY2020 | Dec 31, 2020 | $164.94M | +155.2% |
| FY2019 | Dec 31, 2019 | $64.64M | +18.9% |
| FY2018 | Dec 31, 2018 | $54.37M | +57.8% |
| FY2017 | Dec 31, 2017 | $34.46M | +58.0% |
| FY2016 | Dec 31, 2016 | $21.82M | +53.5% |
| FY2015 | Dec 31, 2015 | $14.21M | +87.6% |
| FY2014 | Dec 31, 2014 | $7.57M | +114.4% |
| FY2013 | Dec 31, 2013 | $3.53M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $65.55M | -3.0% |
| Q2 FY2026 | Jun 30, 2026 | $62.86M | -8.6% |
| Q1 FY2026 | Mar 31, 2026 | $67.87M | -3.0% |
| Q4 FY2025 | Dec 31, 2025 | $71.61M | -6.7% |
| Q3 FY2025 | Sep 30, 2025 | $67.57M | -6.6% |
| Q2 FY2025 | Jun 30, 2025 | $68.78M | -10.4% |
| Q1 FY2025 | Mar 31, 2025 | $69.96M | -14.0% |
| Q4 FY2024 | Dec 31, 2024 | $76.75M | -14.7% |
| Q3 FY2024 | Sep 30, 2024 | $72.38M | -14.1% |
| Q2 FY2024 | Jun 30, 2024 | $76.75M | -12.1% |
| Q1 FY2024 | Mar 31, 2024 | $81.39M | -6.4% |
| Q4 FY2023 | Dec 31, 2023 | $89.94M | +8.4% |
| Q3 FY2023 | Sep 30, 2023 | $84.29M | -0.4% |
| Q2 FY2023 | Jun 30, 2023 | $87.31M | +10.9% |
| Q1 FY2023 | Mar 31, 2023 | $86.99M | -0.5% |
| Q4 FY2022 | Dec 31, 2022 | $82.93M | +13.8% |
| Q3 FY2022 | Sep 30, 2022 | $84.59M | +5.4% |
| Q2 FY2022 | Jun 30, 2022 | $78.70M | -2.6% |
| Q1 FY2022 | Mar 31, 2022 | $87.41M | +12.1% |
| Q4 FY2021 | Dec 31, 2021 | $72.87M | -21.4% |
| Q3 FY2021 | Sep 30, 2021 | $80.25M | +167.9% |
| Q2 FY2021 | Jun 30, 2021 | $80.76M | +250.7% |
| Q1 FY2021 | Mar 31, 2021 | $78.01M | +305.1% |
| Q4 FY2020 | Dec 31, 2020 | $92.70M | +470.6% |
| Q3 FY2020 | Sep 30, 2020 | $29.96M | +90.3% |
| Q2 FY2020 | Jun 30, 2020 | $23.03M | +38.2% |
| Q1 FY2020 | Mar 31, 2020 | $19.26M | +20.5% |
| Q4 FY2019 | Dec 31, 2019 | $16.25M | +19.9% |
| Q3 FY2019 | Sep 30, 2019 | $15.75M | +16.0% |
| Q2 FY2019 | Jun 30, 2019 | $16.67M | +16.1% |
| Q1 FY2019 | Mar 31, 2019 | $15.99M | +23.9% |
| Q4 FY2018 | Dec 31, 2018 | $13.54M | +29.7% |
| Q3 FY2018 | Sep 30, 2018 | $13.58M | +36.3% |
| Q2 FY2018 | Jun 30, 2018 | $14.35M | +90.4% |
| Q1 FY2018 | Mar 31, 2018 | $12.90M | +98.2% |
| Q4 FY2017 | Dec 31, 2017 | $10.45M | +77.2% |
| Q3 FY2017 | Sep 30, 2017 | $9.96M | – |
| Q2 FY2017 | Jun 30, 2017 | $7.54M | – |
| Q1 FY2017 | Mar 31, 2017 | $6.51M | – |
| Q4 FY2016 | Dec 31, 2016 | $5.89M | – |
See a number that looks wrong?